// App-Quantinova.ai

OA15 : IL-13 inhibition used for atopic diseases is associated with risk of psoriatic arthritis

Researchers

Presenter

  • Sizheng Steven Zhao

Principal Investigators

  • Kimme L Hyrich

  • Zenas Z N Yiu

  • Anne Barton

  • John Bowes

Medical Centers

  • Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester, United Kingdom

  • Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Autoimmune (AI)

  • Gastroenterology (GU)

  • Musculoskeletal

Disease

  • Ankylosing spondylitis

  • Rheumatoid arthritis

  • Psoriatic arthritis

  • Ulcerative colitis

  • Crohn's disease

  • Atopic Dermatitis

  • Inflammatory Arthritis

  • Psoriasis

  • Asthma

Biomarkers

  • Interleukin 13

Drug/Treatment

  • tralokinumab

  • CAT-354

  • Dupilumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved